COLLEGIUM PHARMACEUTICAL, INC

COLL · Nasdaq · SIC 2834: Pharmaceutical Preparations
185
SEC Filings

Business Summary

PART I Overview Our mission is to build a leading, diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. We have developed, licensed, and acquired a portfolio of meaningfully differentiated products for use in the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. We commercialize our products, consisting of Jornay PM, Belbuca, Xtampza ER, Nucynta ER and Nucynta IR (collectively the Nucynta ...

Next Earnings

Q2 FY2026 — expected 2026-08-10

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionCOLLdiscussed_in_filing Cybersecurity
topic_mentionCOLLdiscussed_in_filing Trusted Computing
topic_mentionCOLLdiscussed_in_filing Blockchain & Crypto
topic_mentionCOLLdiscussed_in_filing Supply Chain
topic_mentionCOLLdiscussed_in_filing Regulation
topic_mentionCOLLdiscussed_in_filing Healthcare & Bio
topic_mentionCOLLdiscussed_in_filing AI Compute
topic_mentionCOLLdiscussed_in_filing Platform & Ecosystem
topic_mentionCOLLdiscussed_in_filing Sovereign & Government
topic_mentionCOLLdiscussed_in_filing Cybersecurity
topic_mentionCOLLdiscussed_in_filing Trusted Computing
topic_mentionCOLLdiscussed_in_filing Blockchain & Crypto
topic_mentionCOLLdiscussed_in_filing Supply Chain
topic_mentionCOLLdiscussed_in_filing Regulation
topic_mentionCOLLdiscussed_in_filing Healthcare & Bio
topic_mentionCOLLdiscussed_in_filing AI Compute
topic_mentionCOLLdiscussed_in_filing Platform & Ecosystem
topic_mentionCOLLdiscussed_in_filing Sovereign & Government
topic_mentionCOLLdiscussed_in_filing Cybersecurity
topic_mentionCOLLdiscussed_in_filing Trusted Computing

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001628280-26-011992EDGAR75K words
2025-02-272024-12-310001558370-25-001801EDGAR
2024-02-222023-12-310001558370-24-001526EDGAR
2023-02-232022-12-310001558370-23-001900EDGAR
2022-02-242021-12-310001558370-22-001927EDGAR
2021-02-252020-12-310001558370-21-001814EDGAR
2020-02-272019-12-310001558370-20-001625EDGAR
2019-02-272018-12-310001558370-19-001187EDGAR
2018-03-072017-12-310001558370-18-001644EDGAR
2017-03-102016-12-310001558370-17-001629EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001104659-25-107391EDGAR48K words
2025-08-072025-06-300001558370-25-010649EDGAR
2025-05-082025-03-310001558370-25-006960EDGAR
2024-11-072024-09-300001558370-24-014858EDGAR
2024-08-082024-06-300001558370-24-011586EDGAR
2024-05-092024-03-310001558370-24-007601EDGAR
2023-11-072023-09-300001558370-23-017983EDGAR
2023-08-032023-06-300001558370-23-013192EDGAR
2023-05-042023-03-310001558370-23-008087EDGAR
2022-11-032022-09-300001558370-22-016241EDGAR
2022-08-042022-06-300001558370-22-012184EDGAR
2022-05-102022-03-310001558370-22-008090EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-190001104659-26-032166EDGAR52K words
2026-02-260001628280-26-011990EDGAR
2026-01-080001104659-26-001953EDGAR
2025-12-300001104659-25-125026EDGAR
2025-11-060001104659-25-107389EDGAR
2025-08-070001558370-25-010647EDGAR
2025-07-070001104659-25-065981EDGAR
2025-05-190001104659-25-050435EDGAR
2025-05-120001104659-25-047040EDGAR
2025-05-080001558370-25-006957EDGAR

185 total filings indexed. 153 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001267565
TickerCOLL
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedVA

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: d34092e662d90f7c3ec8a720d4904251fe2a6f2b6dc0e43d3e2e809a7f7febdd
parent: 273abbda3a6717b30c685cec5e001a82e75fabf9e6de6c08d470e23f93ea7fef
content hash: 704e8cd596d1ed25271b53c5865c126c5d49e2730d5f8a1dfe6fbe561a65a23e
signed: 2026-04-13T04:44:26.339Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf